New York New York: According to a study on Tuesday, small amounts of a common antibiotic and anti -inflammatory drug can help treat the problem of rare hair loss caused by an incorrect immune response. Researchers at New York University Langon Health said that low doses of antibiotics may also offer less side effects than high doses of the drug.

The study detected lymphocytic scarring alopecia – a rare skin condition in which the body's immune cells damage the hair of the hair, causing hair fall and scars. Physicians usually treat this chronic disease with relatively high doses of antibiotic doxycycline – often long.

However, in a paper published in the journal of the American Academy of Dermatology, the team said that the drug may trigger nausea, vomiting and rashes and discouraged patients to continue taking it.

To determine whether a low dose can work, the team included 241 men and women. Participants, who were treated for several forms of lymphocytic scarning alopecia, revealed that low doses of doxycycline (usually 20 mg taken twice a day) and high doses (up to 100 mg to be taken twice a day) were equally effective.

In particular, there was no significant difference between the two groups on the evaluation of the scalp inflammation, the perception of the hair loss and the density of the hair, the diagnostic measurement of the hair-shake diameter and the hairline recession.

In addition, while 23 percent of people on high diet diet experienced the general negative side effects of doxycycline, only 12 percent of those who took small doses of drug did so. In addition, while 25 percent of the high -dose group people completely stopped taking doxycycline due to gastrointestinal problems, only 16 percent of the low -dose group stopped treatment due to this side effect.

Carly Nadle, a medical student at NYU Grosman School of Medicine, said, “Our findings suggest that doctors can write less doses of doxycycline without compromising the efficacy of treatment and anti -inflammatory benefits to patients suffering from lymphocytic scarring alopecia.